F1F0 ATP synthase synthesizes ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases comprise two structural domains: F1, encompassing the extramembranous catalytic core, and F0, containing the membrane proton channel. These domains are connected by a central and peripheral stalk. ATP synthesis in the F1 catalytic domain is coupled, via a rotary mechanism involving the central stalk subunits, to proton translocation. This protein is a component of the F0 channel, forming part of the peripheral stalk and linking F1 to F0.
KEGG: pmr:PMI3060
STRING: 529507.PMI3060
ATP synthase subunit b functions as part of the F₀ complex of ATP synthase, anchoring the enzyme to the membrane and participating in the proton transport mechanism essential for ATP production. In P. mirabilis, ATP synthase is critical for energy metabolism, particularly during infection when the bacterium must adapt to varying energy requirements during its pathogenic lifecycle. The enzyme is part of the core metabolic machinery that supports both adherent and motile phases of P. mirabilis, which transitions between these states during urinary tract infections . The energy provided through ATP synthase activity likely supports various virulence factors including fimbrial expression and motility systems that require significant energy expenditure during pathogenesis .
The expression of atpF in P. mirabilis responds to environmental cues similar to other metabolic genes. Though specific atpF regulation hasn't been directly characterized in the provided studies, transcriptomic analyses reveal that P. mirabilis significantly modulates its gene expression during infection. Major transcriptional regulators like MrpJ, which affects over 200 genes including those involved in metabolism and virulence, likely influence energy production pathways . During urinary tract infections, P. mirabilis must adapt to the urinary environment, which includes changes in pH due to urease activity and nutrient availability, all of which would affect ATP synthase expression and function. Research shows that genes related to core metabolic functions often show differential expression in vivo compared to laboratory conditions, suggesting that atpF regulation is integrated with the pathogen's adaptive responses .
While specific structural studies on P. mirabilis atpF are not detailed in the provided research, we can infer that it shares the canonical structure of bacterial ATP synthase subunit b: a transmembrane N-terminal domain and a cytoplasmic C-terminal domain that forms a dimeric right-handed coiled-coil structure. The protein likely contains conserved residues for interaction with other ATP synthase subunits, particularly subunit a and the α/β subunits of the F₁ complex. Comparative genomic analyses of P. mirabilis strains (such as HI4320, BB2000, and clinical isolates) would allow researchers to identify sequence conservation in atpF across the species . For experimental characterization, researchers would typically employ techniques such as X-ray crystallography or cryo-electron microscopy after expressing and purifying the recombinant protein.
Genome-wide transposon mutagenesis studies provide insight into gene fitness contributions during infections. While atpF was not specifically highlighted in the transposon studies detailed in the search results, the research paradigm reveals how metabolic genes contribute differently to fitness depending on infection context . For example, research shows that branched-chain amino acid (BCAA) synthesis becomes essential for P. mirabilis during polymicrobial infections with Providencia stuartii, but not during single-species infections .
Similar context-dependent requirements might exist for energy metabolism genes like atpF. To investigate this, researchers could:
Generate atpF mutants using targeted mutagenesis approaches
Conduct competitive index experiments comparing wild-type and atpF mutant strains in:
In vitro culture conditions
Single-species catheter-associated UTI models
Polymicrobial infection models
An experimental design similar to the validation studies shown for other genes (like ilvD and livK) would be appropriate, where fitness is measured by relative bacterial counts in different organs and biofilms . The hypothesis would be that atpF might show differential fitness contributions depending on the metabolic demands imposed by competitive or cooperative interactions with other species.
MrpJ is a transcriptional regulator encoded by the last gene of the MR/P fimbrial operon that affects both motility and adherence in P. mirabilis . Microarray analysis has shown that MrpJ influences the expression of 217 genes related to virulence, secretion, and metabolism . Since ATP production is fundamental to energetically expensive processes like motility (via flagella) and protein synthesis (including fimbriae), there is likely a coordinated relationship between MrpJ regulation and ATP synthase activity.
To investigate this relationship, researchers could:
Perform transcriptional analysis of atpF expression in wild-type versus mrpJ mutant strains
Use chromatin immunoprecipitation (ChIP) techniques to determine if MrpJ directly binds to the atpF promoter region
Measure ATP synthase activity and ATP production levels in various genetic backgrounds (wild-type, mrpJ overexpression, and mrpJ deletion mutants)
Examine how MrpJ-mediated transitions between motile and adherent states affect energy metabolism gene expression
The experimental approach would mirror the ChIP studies conducted for other MrpJ targets, such as the flhDC promoter, which demonstrated direct binding of MrpJ to flagellar regulator promoters .
When expressing recombinant P. mirabilis atpF, researchers must consider how expression conditions might affect protein folding, post-translational modifications, and functionality compared to the native context. For optimal experimental design:
Expression system selection:
E. coli systems typically provide high yields but may lack P. mirabilis-specific chaperones
Homologous expression in P. mirabilis would maintain native folding environments but presents technical challenges
Purification strategy considerations:
Detergent selection for membrane protein extraction (critical for maintaining structure)
Affinity tag placement to minimize interference with function
Removal of tags post-purification if structural studies are planned
Functional assessment techniques:
ATP synthesis assays in reconstituted liposomes
Binding studies with other ATP synthase subunits
Proton translocation measurements
The functionality of recombinant atpF could be assessed by complementation studies in ATP synthase mutants, similar to validation approaches used for other P. mirabilis genes in the transposon mutagenesis studies .
Based on general principles for membrane protein expression and insights from P. mirabilis research, the following methodological approach is recommended:
Expression System Options:
| Expression System | Advantages | Disadvantages | Optimization Parameters |
|---|---|---|---|
| E. coli BL21(DE3) | High expression levels, well-established | Potential folding issues with membrane proteins | Temperature (16-18°C optimal), inducer concentration (0.1-0.5 mM IPTG) |
| E. coli C41/C43 | Designed for membrane protein expression | Lower yields than standard strains | Extended growth period, low inducer concentration |
| P. mirabilis (homologous) | Native folding environment | Technical difficulties, lower yields | Optimization of promoter systems, induction timing |
| Cell-free systems | Avoids toxicity issues | Expensive, limited scale | Detergent selection, lipid supplementation |
For successful expression, researchers should:
Clone atpF with a C-terminal His-tag to minimize interference with the N-terminal membrane domain
Use low-temperature induction (16-20°C) to slow protein production and improve folding
Include membrane-stabilizing agents like glycerol (5-10%) in the growth medium
Consider codon optimization if using E. coli, though P. mirabilis and E. coli share similar codon usage patterns
The purification protocol should employ gentle detergents (such as DDM or LMNG) that maintain the native structure of membrane proteins .
Genetic manipulation of P. mirabilis requires specialized approaches due to its swarming behavior and intrinsic resistance to some antibiotics. Based on successful mutagenesis strategies documented in the search results:
Knockout Strategies:
Allelic exchange using suicide vectors (similar to approaches used for other P. mirabilis genes)
Target vector delivery through conjugation with E. coli donor strains
Selection on media containing appropriate antibiotics
Counter-selection with sucrose if using sacB-based systems
Transposon mutagenesis followed by screening
Complementation Approaches:
Chromosomal integration of atpF under native or inducible promoters
Plasmid-based complementation using vectors demonstrated to be stable in P. mirabilis
Expression of atpF with epitope tags to enable localization studies
Phenotypic Validation:
| Phenotype | Measurement Method | Expected Outcome in ΔatpF | Complementation Assessment |
|---|---|---|---|
| Growth rate | OD600 measurements | Reduced growth, particularly in minimal media | Restoration to wild-type growth rates |
| ATP levels | Luciferase-based assays | Significantly decreased cellular ATP | Return to normal ATP levels |
| Membrane potential | Fluorescent dyes (DiBAC4) | Altered membrane potential | Normalization of membrane potential |
| Swarming motility | Swarming assays on agar | Reduced swarming due to energy deficiency | Restoration of swarming behavior |
| Virulence | Mouse UTI models | Attenuated virulence | Recovery of infection capability |
These methodological approaches build on the successful genetic manipulation strategies demonstrated in the P. mirabilis transposon mutagenesis studies .
Understanding protein-protein interactions within the ATP synthase complex requires specialized techniques suited to membrane protein complexes:
In vitro Interaction Studies:
Co-purification approaches
Tandem affinity purification using differentially tagged subunits
Size exclusion chromatography to isolate intact complexes
Blue native PAGE to preserve native protein-protein interactions
Biophysical characterization methods
Surface plasmon resonance (SPR) for measuring binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Hydrogen-deuterium exchange mass spectrometry to identify interaction interfaces
In vivo Interaction Studies:
Genetic approaches
Bacterial two-hybrid systems adapted for membrane proteins
Suppressor mutation analysis to identify functional interactions
Synthetic lethality screens to identify genetic interactions
Microscopy techniques
Fluorescence resonance energy transfer (FRET) with fluorescently labeled subunits
Super-resolution microscopy for visualizing complex assembly
Immunolocalization using subunit-specific antibodies
Structural Studies:
Cryo-electron microscopy of purified ATP synthase complexes
Cross-linking mass spectrometry to identify proximity relationships
Computational modeling based on homologous structures
These approaches would parallel the chromatin immunoprecipitation and reporter assays used to study MrpJ-DNA interactions , but adapted for protein-protein interactions in a membrane environment.
ATP synthase represents a potential therapeutic target given its essential role in bacterial energy metabolism. Based on insights from P. mirabilis pathogenesis studies:
ATP synthase inhibition would likely affect multiple virulence processes:
Therapeutic targeting considerations:
Specificity for bacterial versus human ATP synthase
Delivery challenges in the urinary tract environment
Potential for resistance development
Experimental approaches to investigate this question:
Sub-inhibitory concentrations of ATP synthase inhibitors in virulence assays
Catheter biofilm formation studies with atpF mutants or under inhibitor treatment
In vivo studies using the mouse catheter model with targeted atpF mutation
Given that metabolism-targeting approaches must consider interactions in polymicrobial settings, researchers should evaluate ATP synthase inhibition in both single-species and polymicrobial contexts, similar to the studies of branched-chain amino acid metabolism in mixed infections .
The catheterized urinary tract presents unique challenges for bacterial metabolism, including fluctuating pH, limited oxygen availability, and changing nutrient profiles. ATP synthase likely plays a crucial role in adaptation to this environment:
pH adaptation considerations:
Biofilm-specific energy requirements:
Different metabolic states exist in biofilm layers
ATP synthesis needs differ between planktonic and biofilm cells
Energy distribution within structured communities
Experimental approaches:
Transcriptional profiling of atpF during biofilm formation vs. planktonic growth
ATP measurements in different biofilm regions
pH-dependent ATP synthase activity assays
Comparative fitness of atpF mutants in catheter biofilms vs. planktonic culture
This research direction would complement existing knowledge of how P. mirabilis adapts its virulence factor expression during catheter colonization by focusing on the energetic aspects of this adaptation.
Systems biology offers powerful frameworks for understanding how individual components like atpF contribute to the broader pathogenic capabilities of P. mirabilis:
Multi-omics integration strategies:
Network modeling approaches:
Construct metabolic models incorporating ATP production/consumption
Develop regulatory networks connecting energy metabolism with virulence circuits
Create predictive models of how energy availability affects virulence expression
Experimental validation methods:
Targeted metabolic flux analysis using isotope labeling
Time-course sampling during infection progression
Perturbation studies with genetic and pharmacological tools
This systems-level understanding would build upon the transcriptomic networks identified for MrpJ and the fitness factor networks revealed by transposon mutagenesis , creating a more comprehensive model of how P. mirabilis coordinates metabolism and virulence.
Current technological limitations constrain our understanding of real-time energy metabolism during infection. Future research would benefit from:
Advanced imaging technologies:
Real-time ATP sensing in live infection models
Single-cell resolution of ATP synthase activity in biofilms
Intravital microscopy compatible with urinary tract infection models
Improved genetic tools:
Inducible/repressible atpF expression systems for temporal control
Site-specific mutagenesis of key residues without polar effects
Reporter systems for ATP levels that function in infection settings
Enhanced infection models:
Microfluidic catheter models that mimic flow conditions
Tissue-engineered bladder models with relevant cell types
Improved animal models that better recapitulate human catheter biofilms
These technological developments would address current limitations in studying dynamic processes during infection and allow for more precise understanding of how ATP synthase function contributes to the complex process of catheter-associated UTIs caused by P. mirabilis .